When faced with evolving analysis plans, minimal client infrastructure, and shifting output volumes, Phastar delivered high-quality ISS and ISE outputs for Cushing syndrome clinical studies.
By combining automation, custom macros, and strategic agility within an FSP model, our team adapted quickly to changing sponsor needs—ensuring consistent quality and on-time delivery despite significant mid-project changes.
This case study demonstrates how innovation, collaboration, and flexibility can transform complex integration challenges into regulatory-ready solutions that add lasting value for the sponsor.
Complete the form to download the full case study.
